German SPCs ROTE LISTE
Germany SPCs ROTE LISTE in a nutshell
The GERMAN SPCs ROTE LISTE® provides detailed information in following aspects:
- Legal data to the German Drugs
- Short Products´Characteristics (SPCs)
With the GERMAN SPCs ROTE LISTE®, medical-pharmaceutical experts such as physicians, pharmacists, clinics, nursing staff, and pharmaceutical-technical assistants receive brief information on human finished medicinal products available in Germany and certain medical devices including EU approvals. These data are compiled from available specialist, usage and product information. In order to be included and published in the RED LISTE®, the pharmaceutical company must register its product or products accordingly. Without registration, the products are not mentioned. The Rote Liste® is a “trusted source” for drug information in Germany as listed by the European Medicines Agency (EMA) .
By licensing the GERMAN SPCs ROTE LISTE® is available in various databases, including via [pharmazie.com].
Suitable for:
Pharma Industry, Pharma Trade, Health Insurance, Regulatory
Source: Rote Liste Service LTD.
Frankfurt am Main, Germany
Related subscription
This database can be accessed after purchasing the subscription package ‘Drug Dictionaries’ or ‘Premium’
These databases could also be interesting for you
Related posts
The Central Nervous System of Modern Healthcare: A Comprehensive Analysis of Medication Databases, Market Access, and Clinical Safety Infrastructure
Executive Summary In the contemporary healthcare ecosystem, the medication database has transcended its traditional role as a static repository of pharmaceutical nomenclature. It has evolved into a dynamic, mission-critical infrastructure that underpins patient...
The Iceberg Search: Navigating the Submerged Depths of Pharmaceutical Intelligence and Drug Databases
1. The Epistemology of Drug Data: Beyond the Visible Web In the pharmaceutical and healthcare industries, information is not merely a utility; it is the fundamental currency of survival, compliance, and therapeutic success. When a regulatory affairs manager, a...
The Strategic Imperative of the Summary of Product Characteristics (SmPC): Regulatory Frameworks, Digital Transformation, and AI-Driven Compliance
Executive Summary The global pharmaceutical ecosystem is currently navigating a period of unprecedented complexity. At the epicenter of this environment—balancing the rigorous demands of regulatory compliance, the clinical needs of healthcare professionals, and the...
Schedule a free demo
Book your personal 30-minute demo and experience how pharmazie.com can revolutionize your daily work routine.
Personalized demo for your industry
Live access to all functions
Individual questions & answers
Non-binding & free of charge
